Genedrive® 96 SARS-CoV-2 Kit is a real-time RT-PCR test for the qualitative detection of SARS-CoV-2 nucleic acids. It addresses the need for high-volume throughput testing and is now being distributed by Sysmex Europe.
In cooperation with near patient molecular diagnostics company genedrive plc, Sysmex Europe GmbH (including local affiliates) is a certified distributor of the Genedrive® 96 SARS-CoV-2 Kit.
Genedrive® 96 SARS-CoV-2 Kit is a real-time RT-PCR test for the qualitative detection of SARS-CoV-2 nucleic acids.
The World Health Organization (WHO) recommends using respiratory samples with a RT-PCR test for SARS-CoV-2 testing, so Genedrive created a one-step CE-IVD PCR Kit to address the need for high-volume throughput testing.
The unique single lyophilised PCR bead format allows for storage at room temperature and eliminates reagent preparation, reduce the risk of errors and variability. The accompanying Genedrive® 96 Exporter software extracts the raw data from real time PCR platforms and analyses the PCR melt-curve data generated using the Genedrive® 96 SARS-CoV-2 Kit. This enables instant analysis of up to 96 results in a convenient graphical user interface, saving time and minimising subjectivity in result interpretation.
If the lab personnel prefer to perform the result interpretation manually, they are also free to do so. The Genedrive® 96 Exporter is an optional software available for free download from the genedrive website.
About genedrive plc (http://www.genedriveplc.com)
genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company has assays on market for the detection of HCV, certain military biological targets, and has tests in development for tuberculosis (mTB). The Company recently announced CE marking of the high throughput Genedrive® 96 SARS-CoV-2 Kit, and a Genedrive® Point of Care version of the assay is in development.